A Predictive Model for Severe COVID-19 in the Medicare Population: A Tool for Prioritizing Primary and Booster COVID-19 Vaccination

被引:8
|
作者
Experton, Bettina [1 ]
Tetteh, Hassan A. [2 ]
Lurie, Nicole [3 ,4 ]
Walker, Peter [5 ]
Elena, Adrien [1 ]
Hein, Christopher S. [1 ]
Schwendiman, Blake [1 ]
Vincent, Justin L. [6 ]
Burrow, Christopher R. [1 ]
机构
[1] Humetrix Inc, Del Mar, CA 90214 USA
[2] Dept Def Joint Artificial Intelligence Ctr JAIC, Warfighter Hlth Mission Team, Arlington, VA 22202 USA
[3] Coalit Epidem Preparedness Innovat CEPI, Washington, DC 20006 USA
[4] Harvard Med Sch, Dept Med, Boston, MA 02115 USA
[5] US Navy, Washington, DC 20376 USA
[6] Amazon Web Serv Inc, Seattle, WA 98109 USA
来源
BIOLOGY-BASEL | 2021年 / 10卷 / 11期
关键词
COVID-19 vaccine prioritization; COVID-19 booster vaccine; severe COVID-19 disease; risk for severe COVID-19 infection; COVID-19 vaccine booster prioritization; Medicare population; severe COVID-19 risk model;
D O I
10.3390/biology10111185
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Simple SummaryWhether it is for COVID-19 primary vaccination or the administration of booster vaccines, prioritization criteria need to be established to optimize COVID-19 vaccination programs accounting for both clinical and social vulnerability risks for severe COVID-19 disease. We developed a dual socio-clinical risk model for severe COVID-19 disease in the Medicare population, which is comprised mostly of individuals aged 65 and over. Our model generated risk levels correlated with regionalized COVID-19 case hospitalization rates and mapped them at the county and zip code levels. The model and map can be used by health jurisdictions to reach out to unvaccinated individuals. Our model approach can also be applied to identify Medicare beneficiaries who were in early vaccination groups to be vaccinated to identify those who might maximally benefit from an additional dose of COVID-19 vaccine if and when vaccine immunity wanes.Recommendations for prioritizing COVID-19 vaccination have focused on the elderly at higher risk for severe disease. Existing models for identifying higher-risk individuals lack the needed integration of socio-demographic and clinical risk factors. Using multivariate logistic regression and random forest modeling, we developed a predictive model of severe COVID-19 using clinical data from Medicare claims for 16 million Medicare beneficiaries and socio-economic data from the CDC Social Vulnerability Index. Predicted individual probabilities of COVID-19 hospitalization were then calculated for population risk stratification and vaccine prioritization and mapping. The leading COVID-19 hospitalization risk factors were non-white ethnicity, end-stage renal disease, advanced age, prior hospitalization, leukemia, morbid obesity, chronic kidney disease, lung cancer, chronic liver disease, pulmonary fibrosis or pulmonary hypertension, and chemotherapy. However, previously reported risk factors such as chronic obstructive pulmonary disease and diabetes conferred modest hospitalization risk. Among all social vulnerability factors, residence in a low-income zip code was the only risk factor independently predicting hospitalization. This multifactor risk model and its population risk dashboard can be used to optimize COVID-19 vaccine allocation in the higher-risk Medicare population.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Prioritizing COVID-19 vaccination by age
    Castro, Marcia C.
    Singer, Burton
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (15)
  • [2] Prioritizing COVID-19 vaccination for people with severe mental illness
    De Hert, Marc
    Mazereel, Victor
    Detraux, Johan
    Van Assche, Kristof
    [J]. WORLD PSYCHIATRY, 2021, 20 (01) : 54 - 55
  • [3] Prioritizing pregnant women for COVID-19 vaccination
    Sarwal, Yamini
    Sarwal, Tanvi
    Sarwal, Rakesh
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2021, 155 (01) : 57 - 63
  • [4] Timing of COVID-19 Vaccination and Rates of Severe COVID-19 Infection
    Kucirka, Lauren
    Lessler, Justin
    Manuck, Tracy
    [J]. OBSTETRICS AND GYNECOLOGY, 2023, 141 : 73S - 73S
  • [5] Booster Vaccination Strategies for "Living With COVID-19"
    Kim, Jung Eun
    Lee, Sunmi
    Kim, Hee-Sung
    [J]. FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [7] Myocarditis Associated With COVID-19 Booster Vaccination
    Aviram, Galit
    Viskin, Dana
    Topilsky, Yan
    Sadon, Sapir
    Shalmon, Tamar
    Taieb, Philippe
    Ghantous, Eihab
    Flint, Nir
    Banai, Shmuel
    Havakuk, Ofer
    [J]. CIRCULATION-CARDIOVASCULAR IMAGING, 2022, 15 (02) : 122 - 124
  • [8] COVID-19 Booster Vaccination Bellwethers: Factors Predictive of Older Adults' Adoption of the Second Booster COVID-19 Vaccine in Israel: A Longitudinal Study
    Ben-David, Boaz M. M.
    Keisari, Shoshi
    Regev, Tali
    Palgi, Yuval
    [J]. JOURNAL OF APPLIED GERONTOLOGY, 2023, 42 (05) : 1113 - 1117
  • [10] Confronting COVID-19 and Prioritizing Aging Population
    Su, Binbin
    Luo, Yannan
    Tian, Yaohua
    Chen, Chen
    Zheng, Xiaoying
    [J]. CHINA CDC WEEKLY, 2023, 5 (10): : 229 - 233